Cervical screening is an important part of preventative women’s health and plays a key role in reducing the risk of cervical cancer. The Cervical Screening Test (CST) has replaced the traditional pap smear test in Australia and is designed to detect human papillomavirus (HPV), the virus responsible for most cases of cervical cancer.
Sexually active women aged 25 to 74 are generally recommended to have a cervical screening test every five years, even if they have received the HPV vaccine. Detecting HPV and abnormal cell changes early may help prevent cervical cancer from developing.